PF292 LOW-DOSE CYTARABINE WITH OR WITHOUT GLASDEGIB IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA: LONG-TERM ANALYSIS OF A PHASE 2 RANDOMIZED TRIAL

Journal article

Open access

Peer reviewed

C. Papayannidis, B.D. Smith, M. Heuser, P. Montesinos, M.A. Sekeres, A. Oriol, G. Schiller, A. Candoni, C. Jamieson, C. Hoang, …

HemaSphere, Vol.3(S1), pp.97-98

2019-06

Files and links (1)

url

https://doi.org/10.1097/01.hs9.0000559380.25053.ccView

Published (Version of record) Open

1 Record Views

Title: PF292 LOW-DOSE CYTARABINE WITH OR WITHOUT GLASDEGIB IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA: LONG-TERM ANALYSIS OF A PHASE 2 RANDOMIZED TRIAL
Creators: C. Papayannidis
B.D. Smith
M. Heuser
P. Montesinos
M.A. Sekeres
A. Oriol
G. Schiller
A. Candoni
C. Jamieson
C. Hoang
W.W. Ma
M. Zeremski
A. O’Connell
G. Chan
J. Cortes
Publication Details: HemaSphere, Vol.3(S1), pp.97-98
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757351502976